UBS lowered the firm’s price target on Eastman Chemical (EMN) to $111 from $115 and keeps a Buy rating on the shares. Eastman Chemical provided weak Q2 guidance as it navigates tariff challenges, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMN:
- Closing Bell Movers: Alphabet up 5% after earnings beat
- Eastman Chemical reports Q1 adjusted EPS $1.91, consensus $1.89
- Eastman Chemical sees Q2 adjusted EPS $1.70-$1.90, consensus $2.16
- Eastman Chemical options imply 4.2% move in share price post-earnings
- EMN Earnings this Week: How Will it Perform?